The gut, its microbiota, and the liver communicate through complex interactions. This communication, known as the gut-liver axis, plays a crucial role in maintaining liver health and preventing disease. We will explore the role of gut microbiota in the gut-liver axis and delve into the emerging microbiota-based therapies that hold promise for liver diseases.
For the first time, a European group of researchers have analyzed the microbiome of more than 2,500 different types of foods. The insights gained will help better identify good and bad ‘bugs’ and improve the quality and safety of existing products. Additionally, the research sheds light on the influence of food microbiome on our own gut microbiome and overall health.
Discover the gut fungi world and their role in human health through our new infographic! Learn about their contribution to nutrient production, metabolism, defense against harmful microorganisms, and the establishment of healthy gut bacteria.
On March 7th and 8th, scientists, healthcare professionals, dietitians, and digital opinion leaders from all over the world converged in Madrid, Spain for the 9th edition of the Gut Microbiota for Health World Summit.
Can these tests help doctors in their daily practice? Who should take a stool test and who should prescribe it? Interview with Andrea Hardy, Fernando Azpiroz and Joël Doré (Part 2)
More and more used, what can fecal microbiota test kits tell us? Three experts give their opinion
12 Mar 2020by Cristina Sáez
We asked Andrea Hardy, Fernando Azpiroz, and Joël Doré, about stool and gut microbiota testing, to know more about it and its limits.
What do we know about the relationship between our gut microbiota and cardiovascular disease?
19 Feb 2020by Megan Mouw
Most of us want to lower our cardiometabolic risk in order to live long and healthy lives; that is, we want to have what doctors define as a low risk of developing cardiovascular disease and diabetes.
New findings in mice suggest autoimmune mechanisms that originate in the gut are silent drivers of Parkinson’s disease
12 Aug 2019by GMFH Editing Team
Recent studies have widened the immune system and the gut microbiota’s role to the pathophysiology of Parkinson’s disease. Scientists suggest that intestinal infections could act as a trigger in Parkinson’s disease, through affecting mitochondrial antigen presentation and cytotoxic T cells establishment in mice.
A recent study, led by Dr. Andrew S. Neish from the Department of Pathology and Laboratory Medicine at Emory University School of Medicine in Atlanta, found that Akkermansia muciniphila and other anaerobic bacteria may promote gut healing in mice.
According to a new study published in Science Advances, being in contact with others may be linked to a healthy, rich and diverse microbiota, at least in chimpanzees, thus providing a healthier and longer existence.
